The intersection of radiopharmaceuticals and nanotechnology has propelled the field of medicine forward, particularly concerning targeted cancer therapies.

Hyderabad: Advancements in imaging technology, theranostics and personalised medicine are reshaping cancer treatment and drug development, said Dr Sridhar Nimmagadda, a professor at Johns Hopkins ...

In recent years, there has been a growing interest in the field of novel theranostics, which encompasses both Positron emission tomography (PET) imaging and radionuclide therapy. Theranostics aims ...

Established in 2022, the Lancet Oncology Commission on Radiotherapy and Theranostics was led by the IAEA and includes experts from 44 academic institutions and medical centres across 23 different ...